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Introduction:  
Elevated serum homocysteine is known to be associated with endothelial dysfunction, which is 
seen in multiple chronic diseases which include, but is not limited to Alzheimer’s, Dementia, and 
cardiovascular disease. This necessitated our investigation into serum homocysteine levels in VA 
patients and their associated comorbid disorders. Our study aimed to investigate comorbidities 
associated with elevated homocysteine levels, defined by being greater than 15 micromole/liter.  
 
Methods: Informatics at the VA was used to obtain a list of 654 patients with homocysteine 
drawn during the period of the study (7/21/2009 through 12/31/2013) at the John D. Dingell 
VAMC. Subjects were adults over 18 years of age. Patient gender, BMI, vitals, vitamin 
supplementation, and associated comorbidities were retrospectively analyzed and documented in 
an Excel file. The data from the excel file were statistically analyzed using SPSS 25. For each 
comorbidity and patient characteristic, homocysteine levels were compared using Independent 
Samples Mann-Whitney U test.  
 
Results: After completing statistical analysis of comorbidities commonly found in our Veteran 
population, those with statistically significant elevated levels (P-value <0.05) of homocysteine 
were found to be Hypertension (P-value 0.001), Chronic Kidney Disease (P-value <0.001), 
Dementia (P-value 0.004), Alzheimer’s (P-value 0.018), Peripheral Vascular Disease (P-value 
0.046), and male gender (P-value 0.037). Of note, psoriasis was not statistically significant (P-
value 0.855).  
 
Conclusion: Elevated homocysteine levels are known to be pro-inflammatory, which likely 
plays a role in their elevation in hypertension, chronic kidney disease, dementia, Alzheimer’s, 
and Peripheral Vascular Disease, necessitating a need to reduce homocysteine levels to improve 
patient outcomes.  
 
 
